| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5615104 | Journal of Clinical Lipidology | 2017 | 35 Pages |
Abstract
Residual risk of ASCVD remains high despite statin treatment and is predicted by specific risk factors and subclinical atherosclerosis. These findings may be helpful for identifying those at highest risk needing more aggressive treatment.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Nathan D. PhD, Yanglu MD, MS, Ruben G.W. PhD, Roger S. MD, Matthew J. MD, Mary MD, MSc, Parveen MD, Veit MD, Michael MD, J. Antonio G. MD,